AcroVal

Device AXOGEN
Total Payments
$104,697
Transactions
9
Doctors
5
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2019 $49,692 3 2
2018 $5,828 2 2
2017 $49,178 4 3

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $45,487 3 43.4%
Grant $18,975 1 18.1%
Education $18,975 1 18.1%
Unspecified $14,375 1 13.7%
Consulting Fee $6,750 2 6.4%
Food and Beverage $135.08 1 0.1%

Payments by Type

General
$90,322
8 transactions
Research
$14,375
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Exploration of the Sensitivity and Specificity of the PSSD for Chemotherapy Induced Peripheral Neuropathy and Sensitivity after Autologous Breast Reconstruction AxoGen $14,375 0

Top Doctors Receiving Payments for AcroVal

Doctor Specialty Location Total Records
, M.D Specialist Towson, MD $64,462 4
, MD Plastic Surgery Within the Head and Neck San Francisco, CA $18,975 1
Unknown Chicago, IL $14,375 1
, D.O Orthopaedic Surgery Ocala, FL $4,000 1
, M.D Surgery Boston, MA $2,750 1
, M.D Surgery Philadelphia, PA $135.08 1

About AcroVal

AcroVal is a device associated with $104,697 in payments to 5 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is AXOGEN.

Payment data is available from 2017 to 2019. In 2019, $49,692 was paid across 3 transactions to 2 doctors.

The most common payment nature for AcroVal is "Royalty or License" ($45,487, 43.4% of total).

AcroVal is associated with 1 research study, including "Exploration of the Sensitivity and Specificity of the PSSD for Chemotherapy Induced Peripheral Neuropathy and Sensitivity after Autologous Breast Reconstruction" ($14,375).